• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹麦全国范围内,在接受原发性乳腺癌治疗的女性队列中,诊断后使用不同类型的补充和替代医学(CAM)的流行情况、社会人口学和临床预测因素。

Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer.

机构信息

Psychooncology Research Unit, Aarhus University Hospital and Aarhus University, Denmark.

出版信息

Eur J Cancer. 2009 Dec;45(18):3172-81. doi: 10.1016/j.ejca.2009.09.005. Epub 2009 Oct 5.

DOI:10.1016/j.ejca.2009.09.005
PMID:19811905
Abstract

AIM

This study investigated the prevalence and predictors of use of complementary and alternative medicine (CAM) in a nationwide inception cohort of Danish women treated for early-stage breast cancer as well as differences in user patterns for individual types of CAM.

METHODS

Use of CAM since the time of diagnosis was assessed 12-16 weeks post-surgery for the 3343 women (age 18-70) included in the study (response rate: 68%). Socio-demographic and clinical variables were obtained from national longitudinal registries.

RESULTS

40.1% of the women had used one or more types of CAM. Users were younger than non-users. Age adjusted analyses showed that CAM users were characterised by absence of comorbidity, higher educational level, higher personal income, higher social status, being divorced/separated and living in the metropolitan area of Copenhagen. Multivariate analyses revealed that chemotherapy was the only clinical and treatment-related predictor of CAM use, and that CAM users were more likely to be of normal weight and non-smokers. Of CAM users, 33.7% believed that CAM would have a positive influence upon their breast cancer. Different characteristics distinguished users of individual types of CAM.

CONCLUSION

The results of this first nationwide study of utilisation of CAM in breast cancer show that CAM users are healthier and more likely to have higher socio-economic status than non-users. Different user patterns for individual types of CAM may be overlooked, when different types of CAM are treated as one homogeneous category.

摘要

目的

本研究调查了丹麦全国范围内早期乳腺癌女性患者中使用补充和替代医学(CAM)的流行率和预测因素,以及个别 CAM 类型的使用模式差异。

方法

对纳入研究的 3343 名女性(年龄 18-70 岁)在手术后 12-16 周时评估了自诊断以来使用 CAM 的情况(应答率:68%)。社会人口统计学和临床变量来自国家纵向登记册。

结果

40.1%的女性使用过一种或多种类型的 CAM。使用者比非使用者年轻。年龄调整分析表明,CAM 使用者无合并症、受教育程度较高、个人收入较高、社会地位较高、离婚/分居和居住在哥本哈根大都市区。多变量分析显示,化疗是使用 CAM 的唯一临床和治疗相关预测因素,而 CAM 使用者更有可能体重正常且不吸烟。在 CAM 使用者中,33.7%的人认为 CAM 会对他们的乳腺癌产生积极影响。不同类型的 CAM 使用者具有不同的特征。

结论

这项关于乳腺癌患者 CAM 使用情况的全国性研究的结果表明,CAM 使用者比非使用者更健康,更有可能具有较高的社会经济地位。当不同类型的 CAM 被视为一个同质类别时,可能会忽略个别 CAM 类型的不同使用模式。

相似文献

1
Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer.丹麦全国范围内,在接受原发性乳腺癌治疗的女性队列中,诊断后使用不同类型的补充和替代医学(CAM)的流行情况、社会人口学和临床预测因素。
Eur J Cancer. 2009 Dec;45(18):3172-81. doi: 10.1016/j.ejca.2009.09.005. Epub 2009 Oct 5.
2
Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer.乳腺癌患者完成正规西医治疗后女性使用补充和替代医学的情况。
Altern Ther Health Med. 2004 Jan-Feb;10(1):52-7.
3
Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer.补充和替代医学的使用、支出与早期乳腺癌患者的生活质量。
Nurs Res. 2010 Jan-Feb;59(1):58-66. doi: 10.1097/NNR.0b013e3181c3bd26.
4
Prevalence and risk of depressive symptoms 3-4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer.在一项针对丹麦早期乳腺癌女性患者的全国性队列研究中,术后3 - 4个月抑郁症状的患病率及风险。
Breast Cancer Res Treat. 2009 Jan;113(2):339-55. doi: 10.1007/s10549-008-9920-9. Epub 2008 Feb 16.
5
Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death.使用补充和替代医学与对乳腺癌风险和死亡的认知增加有关。
Breast Cancer Res Treat. 2005 Mar;90(2):139-48. doi: 10.1007/s10549-004-3779-1.
6
Use of complementary and alternative medicine (CAM) and changes in depressive symptoms from 3 to 15 months after surgery for primary breast cancer: results from a nationwide cohort study.使用补充和替代医学(CAM)与原发性乳腺癌手术后 3 至 15 个月抑郁症状的变化:一项全国性队列研究的结果。
Breast Cancer Res Treat. 2013 Sep;141(2):277-85. doi: 10.1007/s10549-013-2680-1. Epub 2013 Sep 14.
7
Patterns of the use of complementary and alternative medicine in women with metastatic cancer.转移性癌症女性使用补充和替代医学的模式。
Cancer Nurs. 2010 May-Jun;33(3):194-200. doi: 10.1097/NCC.0b013e3181c295ac.
8
Frequency of use of complementary and alternative medicine in women with breast cancer.乳腺癌女性使用补充和替代医学的频率。
Oncol Nurs Forum. 2002 Nov-Dec;29(10):1445-52. doi: 10.1188/02.ONF.1445-1452.
9
Complementary medicine use among women enrolled in a genetic testing program.参与基因检测项目的女性对补充替代医学的使用情况。
Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):321-6.
10
Complementary and alternative medicine (CAM) among hospitalised patients: reported use of CAM and reasons for use, CAM preferred during hospitalisation, and the socio-demographic determinants of CAM users.住院患者中的补充和替代医学(CAM):CAM 的报告使用情况和使用原因、住院期间首选的 CAM 以及 CAM 用户的社会人口学决定因素。
Complement Ther Clin Pract. 2011 Nov;17(4):199-205. doi: 10.1016/j.ctcp.2011.05.001. Epub 2011 Jun 25.

引用本文的文献

1
The Self-Administered Use of Complementary and Alternative Medicine (CAM) Supplements and Antioxidants in Cancer Therapy and the Critical Role of Nrf-2-A Systematic Review.癌症治疗中补充与替代医学(CAM)补充剂和抗氧化剂的自我给药使用以及Nrf-2的关键作用——一项系统评价
Antioxidants (Basel). 2022 Oct 30;11(11):2149. doi: 10.3390/antiox11112149.
2
"Is the Pain a Sign of Healing?": Cancer Patients' Experiences of Energy Healing in a Pragmatic Trial.“疼痛是否是治愈的信号?”:一项实用试验中癌症患者对能量疗愈的体验。
Integr Cancer Ther. 2022 Jan-Dec;21:15347354221118328. doi: 10.1177/15347354221118328.
3
Efficacy of open dialogue about complementary and alternative medicine compared with standard care in improving quality of life in patients undergoing conventional oncology treatment (CAMONCO 2): protocol for a randomised controlled trial.
补充和替代医学开放对话与常规肿瘤治疗标准护理比较对改善常规肿瘤治疗患者生活质量的疗效(CAMONCO 2):一项随机对照试验的方案。
BMJ Open. 2022 Apr 25;12(4):e059960. doi: 10.1136/bmjopen-2021-059960.
4
Complementary and alternative medicine use among older adults with musculoskeletal pain: findings from the European Social Survey (2014) special module on the social determinants of health.患有肌肉骨骼疼痛的老年人使用补充和替代医学的情况:来自欧洲社会调查(2014年)健康社会决定因素特别模块的研究结果。
Br J Pain. 2022 Feb;16(1):109-118. doi: 10.1177/20494637211023293. Epub 2021 Jun 13.
5
Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.癌症患者中使用草药的患病率:一项系统评价和荟萃分析。
Evid Based Complement Alternat Med. 2021 May 17;2021:9963038. doi: 10.1155/2021/9963038. eCollection 2021.
6
Self-medication with herbal medicine and breast cancer survival: a prospective monocentric study.中草药自我药疗与乳腺癌生存:一项前瞻性单中心研究。
J Cancer Res Clin Oncol. 2021 Nov;147(11):3401-3407. doi: 10.1007/s00432-021-03600-y. Epub 2021 Mar 21.
7
Complementary Methods in Cancer Treatment-Cure or Curse?癌症治疗中的补充方法——是福还是祸?
Int J Environ Res Public Health. 2021 Jan 5;18(1):356. doi: 10.3390/ijerph18010356.
8
Use of Complementary and Alternative Medicine among Young Patients with Breast Cancer.年轻乳腺癌患者对补充和替代医学的使用情况。
Breast Care (Basel). 2020 Apr;15(2):163-170. doi: 10.1159/000501193. Epub 2019 Jul 19.
9
Complementary and alternative medicine use in adults with autism spectrum disorder in Germany: results from a multi-center survey.成人自闭症谱系障碍中补充和替代医学的使用:来自一项多中心调查的结果。
BMC Psychiatry. 2019 Feb 1;19(1):53. doi: 10.1186/s12888-019-2043-5.
10
Complementary and Alternative Medicines and Patients With Breast Cancer: A Case of Mortality and Systematic Review of Patterns of Use in Patients With Breast Cancer.补充与替代医学与乳腺癌患者:一例死亡病例及乳腺癌患者使用模式的系统评价
Plast Surg (Oakv). 2017 Nov;25(4):275-283. doi: 10.1177/2292550317716126. Epub 2017 Aug 22.